Connect with us

Technology

IndoStar Capital Finance Core (VF + HFC) AUM grows 54% and Disbursements 71% YoY

Published

on

MUMBAI, India, Aug. 1, 2024 /PRNewswire/ — 

Q1 FY25 Quarter Performance:

Core AUM (VF + HFC) at ₹ 8,718 crore, up 54% YOY from ₹ 5,669 in Q1FY24Robust demand for used CV: VF AUM at ₹ 6,323 crore, up 13%, QOQ and 61% YOYAffordable Home Finance AUM at ₹ 2,395 crore, up 38% YOY from Q1 FY24

Q1 FY25 Highlights (Consolidated):

AUM at ₹ 9,565 crore, up 9% from ₹ 8,763 crore in Q4 FY24 and up 19% YOY from Q1 FY24Core AUM (CV + HFC) ~ ₹ 8,718 crore (91% of total), up 11% from ~ ₹ 7,864 crore in Q4FY24, up 54% YOYCore Disbursements (CV + HFC) of ₹ 1,618 crore, up 74% YOY from ₹ 945 crore in Q1 FY24Debt/Equity Ratio at 2.3x for Q1 FY25Gross Stage 3 assets at 4.19% for Q1 FY25Net Stage 3 assets are at 2.08% for Q1 FY25

Q1 FY25 Highlights (Standalone – ICF):

AUM at ₹ 7,170 crore, up 10% from ₹ 6,493 crore in Q4 FY24VF AUM at ₹ 6,323 crore, up 13% from ₹ 5,594 crore in Q4 FY24 and up 61% YOY from Q1 FY24VF Disbursements at ₹ 1,407 crore, up 90% from ₹ 740 crore in Q1FY24Debt/Equity Ratio at 1.96xGross Stage 3 assets at 4.97% for Q1 FY25Net Stage 3 assets are at 2.36% for Q1 FY25Strong Capital Adequacy at 27.7%, on a standalone basis

Q4 FY24 Highlights (HFC – Subsidiary):

AUM at ₹ 2,395 crore, up 5% from ₹ 2,270 crore in Q4 FY24, and up 38% YOY from Q1 FY24Debt/Equity Ratio at 2.62x timesGross Stage 3 assets at 1.34% for Q1 FY25Net Stage 3 assets at 1.06% for Q1 FY25Strong Capital Adequacy at 56.2%, on a standalone basis

IndoStar, a middle-layered non-banking finance company (NBFC) registered with the Reserve Bank of India, announced its financial results for the quarter June 30th, 2024, earlier today.

The company AUM at ₹9,565 crore, is up 9% from ₹8,763 crore in Q4 FY24. The company continued to maintain a healthy asset quality, with Gross NPAs at 4.19% in Q1 FY25. At a consolidated level, the Company delivered a PAT of ₹25 crore for Q1 FY25.

Progress on some key strategic initiatives is detailed here:

Year-on-Year Disbursement Growth

The company’s core (VF + HFC) disbursements for Q1 FY25 at ₹1,618 crore grew 71% YOY, compared to ₹945 crore disbursed over the same period last year. VF disbursements at ₹ 1,407 crore grew 86% (Q1 FY24 disbursement of ₹ 755 crore), while Housing Finance disbursements at ₹ 211 crore were up 11% (Q1 FY24 disbursement of ₹ 190 crore).

Launch of SME Micro LAP business

During the quarter, the Company began piloting the Small Business Loans product where the customers can avail loan ranging from ₹ 2 lakh to ₹ 7 lakh. The Company aims to help hyper-local, nano-enterprises, shopkeepers, and small and medium businesses (SMEs). The new Small Business Loans product offers secured loans for personal or business needs, against collateral offered by the customer.

Senior Management update

Mr. Randhir Singh joined as a Whole Time Director and Executive Vice Chairman of the Company effective July 22, 2024. Mr. Randhir Singh has over 29 years of experience in the areas of MSME Lending, Structured Finance, Debt Capital Markets, Corporate Finance, Sales and Trading, FX and Interest Rate derivatives, Risk Management, Asset Management and Banking Operations in banking and financial services sector. He will partner with the broader management team to deliver the growth strategy and drive value creation at IndoStar.

IndoStar Capital Finance Limited (“ICFL”) (Standalone) Financial performance

ICFL delivered a PAT of ₹ 11 crore in Q1 FY25. The AUM for ICFL stands at ₹ 7,170 crore out of which the retail vehicle finance business is ₹ 6,323 crore. Disbursements during the quarter stood at ₹ 1,416 crore, up 88% from ₹ 755 crore in Q1 FY24. With a focus on collections through the quarter, Gross Stage 3 remains flat at 4.97% in Q1 FY25; Net Stage 3 stood at 2.36%. The company maintained a strong Capital Adequacy Ratio (CAR) of 27.7% on a standalone basis. Debt equity ratio stood at 1.95x.

IndoStar Home Finance Private Limited (“IHFPL”) Financial Performance

IHFPL delivered a PAT of ₹ 14 crore in Q1 FY25 aided by AUM growth and securitization transactions. The AUM in IHFPL stands at ₹ 2,395 crore in Q1 FY25, up 38% from ₹1,741 crore in Q1 FY24. IHFPL continues to deliver on its core strategy of providing affordable housing loans in semi-rural and rural markets, while maintaining healthy asset quality. The company reported Gross Stage 3 assets at 1.3%. IHFPL has a Capital Adequacy Ratio (CAR) of 56.2%.

Key Performance Highlights (Consolidated):

Particulars (₹ in crs)

Q1FY25

Q4FY24

Q-o-Q %

Q1FY24

Y-o-Y %

Net Revenue from operations

192

282

(32 %)

145

32 %

Operating expenses

(139)

(139)

0 %

(115)

20 %

Pre-provision operating profit

53

143

(63 %)

30

77 %

Profit after tax

25

35

(29 %)

39

(36 %)

CAR (%) Standalone

27.7 %

28.9 %

34.4 %

Leverage (D/E)

2.3x

2.3x

1.9x

About IndoStar Capital Finance Limited

IndoStar is a non-banking finance company (NBFC) registered with the Reserve Bank of India classified as a Middle layered NBFC. With Brookfield & Everstone as co-promoters, IndoStar is a professionally managed and institutionally owned entity engaged in providing used and new commercial vehicle financing and affordable Home Finance through its wholly owned subsidiary, IndoStar Home Finance Private Limited.

For more information, visit www.indostarcapital.com.

Safe Harbor

This document is to provide the general background information about the Company’s activities as at the date of the release. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation that any investor should subscribe / purchase the company shares. The Company makes no representation or warranty, express or implied, as to, and does not accept any responsibility or liability with respect to, the fairness, accuracy, completeness or correctness of any information contained herein. This release may include certain forward-looking statements. These statements include descriptions regarding the intent, belief or current expectations of the Company or its directors and officers with respect to the results of operations and financial condition of the Company. These statements can be recognized by the use of words such as ”expects”, “plans”, ‘will”, “estimates”, “projects”, or other words of similar meaning. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those in such forward-looking statements as a result of various factors and assumptions which the Company believes to be reasonable in light of its operating experience in recent years. The risks and uncertainties relating to these statements include, but not limited to, risks and uncertainties, regarding fluctuations in earnings, our ability to manage growth, competition, our ability to manage our international operations, government policies, regulations, etc. The Company does not undertake any obligation to revise or update any forward-looking statement that may be made from time to time by or on behalf of the Company including to reflect actual results, changes in assumptions or changes in factors affecting these statements. Given these risks, uncertainties and other factors, viewers of this release are cautioned not to place undue reliance on these forward-looking statements. This release may contain certain currency exchange rates and the same have been provided only for the convenience of reader.

 

View original content:https://www.prnewswire.com/in/news-releases/indostar-capital-finance-core-vf–hfc-aum-grows-54-and-disbursements-71-yoy-302212019.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Dana-Farber Cancer Institute Partners with Clinical.ly to Enhance Regulatory Operations with eReg Solutions

Published

on

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — The Dana-Farber Cancer Institute, a world leader in cancer treatment and research, chose Clinical.ly’s (www.clinical.ly) Research Suite™ to streamline regulatory operations, marking a significant step toward more efficient and compliant clinical trial management. Dana-Farber joins a growing number of research organizations that leverage Clinical.ly’s innovative solutions to streamline clinical trial processes. Clinical.ly’s eReg platform offers a comprehensive, paperless solution that centralizes regulatory workflows, ensuring compliance and transparency across clinical trials.

“We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO.

This partnership continues Clinical.ly’s success in providing best-in-class enterprise tools for conducting clinical research. “We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO. “Our eReg platform and wider set of features in Clinical.ly Research Suite™ will empower that renowned organization, and we all look forward to supporting their teams.”

About Clinical.ly Research Suite™ 

Clinical.ly Research Suite™ is a comprehensive solution that eliminates traditional, paper-based processes. By automating and centralizing essential workflows in the Clinical.ly Research Suite™, organizations achieve huge efficiency improvements, greater trial oversight, document management, and regulatory compliance. The Clinical.ly Research Suite™ includes:

eReg: A best-in-class electronic regulatory bindereSource: An intuitive & feature-rich, paperless data capture solution that streamlines data collection from trial participantseConsent: A fully digital solution for capturing informed consent, improving participant engagement and site complianceClinicallySign: 21 CFR Part 11 compliant eSignature functionalityClinicallyPay: A secure and instantaneous participant stipend payment and reimbursement solution

About Dana-Farber Cancer Institute

Founded in 1947, Dana-Farber Cancer Institute is committed to providing adults and children with the best treatment available today while developing tomorrow’s cures through cutting-edge research. Based in Boston, Dana-Farber is a teaching affiliate of Harvard Medical School and ranks consistently as one of the top cancer hospitals in the world.

About Clinical.ly

Clinical.ly provides differentiated, cloud-native technology solutions to the clinical research industry, enabling research organizations to conduct studies with greater efficiency and ease. Clinical.ly is dedicated to developing technology that eliminates tedious manual labor, allowing clinical research professionals to focus on patient care.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dana-farber-cancer-institute-partners-with-clinically-to-enhance-regulatory-operations-with-ereg-solutions-302253690.html

SOURCE Clinical.ly

Continue Reading

Technology

Fall Into Creativity with the Monport Laser Fall Sale

Published

on

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — Experience laser innovation this Fall with Monport Laser, an industry frontrunner in laser engraving and cutting technology, with an exclusive Fall Sale offering incredible discounts and free accessories on a wide range of high-performance laser engraving machines. From September 19th to September 30th, customers can take advantage of this limited-time opportunity to elevate their laser engraving businesses with cutting-edge laser innovation at unbeatable prices.

Monport Laser has been dedicated to providing innovative and reliable laser machines that empower businesses and individuals to achieve their goals. With a focus on quality, precision, and customer satisfaction, Monport Laser has established itself as a trusted leader in the industry. Their commitment to excellence is evident in every laser they produce, ensuring exceptional performance, reliability, and value.

Embrace the Power of CO2 Laser Technology with Exclusive Offers

Monport Laser will offer two free accessories with selected CO2 laser machines during the Monport Fall sale. These versatile lasers are ideal for various applications, including engraving, cutting, and marking wood, acrylic, leather, and more. By taking advantage of this Fall sale, laser engraving businesses can enhance their productivity and expand their creative possibilities.

Experience Unmatched Value with Fiber Laser Discounts

Monport Laser offers substantial discounts of up to $4200 and 3 free accessories on selected models for those seeking the precision and speed of fiber laser technology. Fiber lasers are renowned for their ability to process metals with exceptional efficiency and accuracy, making them indispensable for metal fabrication, manufacturing, and jewelry production. Additionally, customers purchasing fiber lasers during the Fall sale will receive three free accessories, further sweetening the deal.

Elevate Your Desktop Laser Experience with a Free Water Chiller

Monport Laser is committed to providing comprehensive solutions for businesses of all sizes. As part of the Fall sale, customers who purchase the 40W Desktop laser will receive a Free Water Chiller Cw3000. This essential accessory ensures optimal cooling and performance, prolonging the lifespan of the laser and guaranteeing consistent results.

Discover Additional Savings on a Wide Range of Accessories

Monport Laser offers an additional 20% discount on selected accessories to complete your laser setup. From lenses and nozzles to rotary tables and smoke extraction systems, customers can find everything they need to maximize the potential of their laser machines.

Unleash Your Creativity and Productivity

Monport Laser’s Fall sale is the perfect opportunity to invest in laser technology that empowers your business or fuels your creative passions. With exceptional discounts and free accessories, you can acquire the ideal laser solution to meet your needs and budget.

Whether you’re an entrepreneur, artist, or manufacturer, Monport Laser’s advanced laser machines offer unparalleled precision, versatility, and reliability. Take advantage of this limited-time Fall sale and unlock your projects’ full potential for laser innovation.

About Monport Laser

Monport Laser is a global leader in designing, manufacturing, and distributing high-quality laser machines and accessories. With a commitment to innovation and customer satisfaction, Monport Laser provides cutting-edge solutions for various industries, including manufacturing, engraving, marking, and more.

For more information, visit monportlaser.com and follow them on social media for the latest updates.

Website: https://www.monportlaser.com/

 

 

 

View original content:https://www.prnewswire.com/news-releases/fall-into-creativity-with-the-monport-laser-fall-sale-302253699.html

SOURCE Monport Laser

Continue Reading

Technology

MEDIA ADVISORY – Minister Wilkinson to Make a Critical Minerals Infrastructure Announcement

Published

on

By

VANCOUVER, BC, Sept. 19, 2024 /CNW/ – The Honourable Jonathan Wilkinson, Minister of Energy and Natural Resources, and Ranj Pillai, the Premier of Yukon, will make a funding announcement in support of critical minerals infrastructure projects. A media availability will follow.

Date: September 20, 2024

Time: 10:30 a.m. PT

All accredited media are asked to pre-register by emailing media@nrcan-rncan.gc.ca. A dial-in line is available for media and will be provided upon registration.

Follow us on LinkedIn

SOURCE Natural Resources Canada

Continue Reading

Trending